Type 2 diabetes in children and adolescents

The Lancet

Volumn 373, Issue 9677, 2009, Pages 1743-1744

  Weigensberg, Marc J ^a   Goran, Michael I ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INCRETIN; INSULIN; METFORMIN; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; ETHNIC DIFFERENCE; FOOD AND DRUG ADMINISTRATION; GLYCEMIC CONTROL; HEREDITY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID STORAGE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 65649140903     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60961-2     Document Type: Note

References (12)

1. Goran M.I., Davis J., Kelly L., et al. Low prevalence of pediatric type 2 diabetes: where's the epidemic?. J Pediatr 152 (2008) 753-755
2. Dabelea D., Bell R.A., D'Agostino Jr. R.B., et al. Incidence of diabetes in youth in the United States. JAMA 297 (2007) 2716-2724
3. Goran M.I., Lane C.J., Toledo-Corral C.M., and Weigensberg M.J. Persistence of pre-diabetes in overweight Hispanic children: association with progressive insulin resistance, poor β-cell function, and increasing visceral fat. Diabetes 57 (2008) 3007-3012
4. Weiss R., Taksali S., Tamborlane W., Burgert T., Savoye M., and Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28 (2005) 902-909
5. Goran M.I., and Gower B.A. Longitudinal study on pubertal insulin resistance. Diabetes 50 (2001) 2444-2450
6. Goran M.I., Bergman R.N., Cruz M.L., and Watanabe R. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25 (2002) 2184-2190
7. Buchanan T.A., Xiang A.H., Peters R.K., et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51 (2002) 2796-2803
8. Rosenbloom A., Silverstein J., Amemiya S., Zeitler P., and Klingensmith G. ISPAD clinical practice consensus guidelines 2006-2007: type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes 9 (2008) 512-526
9. August G.P., Caprio S., Fennoy I., et al. Prevention and treatment of pediatric obesity: an Endocrine Society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab 93 (2008) 4576-4599
10. Weng J., Li Y., Xu W., et al. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371 (2008) 1753-1760
11. Jones K.L., Arslanian S., Peterokova V.A., Park J.S., and Tomlinson M.J. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25 (2002) 89-94
12. The TODAY Study Group. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 8 (2007) 74-87